Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 3Colorectal Neoplasms 3Pancreatic Neoplasms 2Colonic Neoplasms 2Choledocholithiasis 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Polyps 1Personal Satisfaction 1Patient Satisfaction 1Parasomnias 1Pancreatitis 1Pain, Postoperative 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Liposarcoma 1Glioblastoma 1Diverticulosis, Colonic 1Choledochal Cyst 1Cholangitis 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Breast Neoplasms 1Anxiety Disorders 1Adenocarcinoma of Lung 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Midazolam × Gastrointestinal × Clear all
NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed
63 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡